National Institute on Drug Abuse; Notice of Closed Meeting

[Federal Register Volume 64, Number 16 (Tuesday, January 26, 1999)]
[Notices]
[Page 3956]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-1722]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel ``Analytical Chemistry and Stability Testing of 
Treatment Drugs''.
    Date: February 17, 1999.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda Holiday Inn, 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Program Review, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 5600 Fishers Lane, Room 10-42, Rockville, 
MD 20857, (301) 443-1644.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: January 19, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-1722 Filed 1-25-99; 8:45 am]
BILLING CODE 4140-01-M